Cita APA

Behrens, F., Koehm, M., Schwaneck, E. C., Schmalzing, M., Gnann, H., Greger, G., . . . Burkhardt, H. (2018). Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab. Rheumatology (Oxford).

Chicago Style Citation

Behrens, Frank, Michaela Koehm, Eva C. Schwaneck, Marc Schmalzing, Holger Gnann, Gerd Greger, Hans-Peter Tony, i Harald Burkhardt. "Minimal Disease Activity Is a Stable Measure of Therapeutic Response in Psoriatic Arthritis Patients Receiving Treatment With Adalimumab." Rheumatology (Oxford) 2018.

Cita MLA

Behrens, Frank, et al. "Minimal Disease Activity Is a Stable Measure of Therapeutic Response in Psoriatic Arthritis Patients Receiving Treatment With Adalimumab." Rheumatology (Oxford) 2018.